Skip to content

    Denali Therapeutics (DNLI) stock price & financials

    View DNLI earnings calls

    Overview

    Price

    Market Cap

    Sector

    Rank

    Performance+53.8% 1Y

    Financials

    Income Statement

    Financial Trajectories

    11
    Quarterly
    MetricQ3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Trend
    EarningsRevenue
    $0
    $0
    $0
    $3.60M
    Operating Profit
    -$123.19M
    -$129.85M
    -$145.58M
    -$134.96M
    -$137.43M
    -11.6%
    -$137.37M
    -5.8%
    -$137.36M
    +5.6%
    -$130.54M
    +3.3%
    Stable
    Net Profit
    -$107.19M
    -$114.75M
    -$132.97M
    -$124.12M
    -$126.90M
    -18.4%
    -$128.55M
    -12.0%
    -$128.45M
    +3.4%
    -$127.55M
    -2.8%
    Weakening
    EPS
    $-0.63
    $-0.78
    $-0.72
    $-0.74
    -17.5%
    $-0.69
    +11.5%
    $-0.68
    +5.6%
    Strengthening
    Other Income
    Interest
    Depreciation
    Profit before Tax
    MarginsOPM
    -3622.1%
    Tax
    ReturnsROIC
    3.8%
    4.1%
    4.7%
    4.4%
    4.5%
    +18.4%
    4.6%
    +12.0%
    4.6%
    -3.4%
    4.5%
    +2.8%
    Strengthening

    Balance Sheet

    Balance Sheet

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    AssetsCash & Equivalents$77.12M$79.45M$507.14M$293.48M$218.04M$127.11M$174.96M$205.33M$201.53M
    Short-Term Investments$387.17M$335.91M$962.55M$571.93M$1.12B$907.40M$657.37M$662.55M$508.94M
    Total Current Assets$480.84M$430.03M$1.50B$897.23M$1.37B$1.06B$864.44M$900.66M$753.93M
    Net PP&E$25.16M$80.66M$73.46M$69.61M$74.52M$71.64M$78.10M$71.40M$66.72M
    Goodwill
    Intangibles$0$35.25M
    Total Assets$661.98M$553.23M$1.60B$1.40B$1.46B$1.15B$1.37B$1.14B$1.16B
    LiabilitiesTotal Current Liabilities$32.79M$45.34M$71.70M$378.25M$363.92M$77.98M$102.21M$98.35M$90.08M
    Short-Term Debt
    Long-Term Debt
    Long-Term Leases$68.86M$64.17M$58.55M$53.03M$44.98M$36.67M$27.21M$22.03M
    Total Liabilities$115.14M$158.34M$453.75M$441.87M$417.81M$122.96M$144.50M$131.09M$322.78M
    EquityCommon Stock & APIC$1.27M$1.29M$1.53M$1.55M$1.69M$1.71M
    Retained Earnings-$227.94M-$425.55M-$354.42M-$645.00M-$970.99M-$1.12B-$1.54B-$2.05B-$2.31B
    Total Equity$546.85M$394.89M$1.15B$962.29M$1.04B$1.03B$1.23B$1.01B$835.18M
    HighlightsNet Cash / (Debt)

    Cash Flow

    Cash Flow

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    ActivitiesCash from Operating$50.12M-$151.58M$416.15M-$211.39M-$244.72M-$357.99M-$347.69M-$412.60M-$434.04M
    Cash from Investing-$287.42M$147.71M-$623.21M-$21.63M-$141.39M$249.31M-$88.76M$255.28M$68.98M
    Cash from Financing$97.02M$6.19M$634.75M$19.35M$310.67M$17.82M$484.30M$189.22M$425.38M
    SummaryCapital Expenditure-$3.39M-$17.92M-$3.10M-$8.50M-$17.83M-$12.94M-$15.91M-$9.50M-$3.42M
    Free Cash Flow$46.72M-$169.50M$413.06M-$219.89M-$262.55M-$370.93M-$363.61M-$422.10M-$437.46M
    FCF Margin36.2%-635.3%123.1%-451.9%-242.1%-112.2%

    Ratios